NIRRIN TECHNOLOGIES INC
formerly NirrinMaking Medicines Easier to Make
Billerica, United States · Founded 2024 · $15.2M raised
- Headquarters
- Billerica, Massachusetts
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- nirrin.tech
- Total Funding
- $15.2M
- Last Round
- $6.7M Venture RoundJun 2026
- Rounds
- 2
About
Nirrin Technologies develops high-precision tunable laser spectroscopy (HPTLS) analytical systems for biopharma biomanufacturing. Their Atlas system provides at-line, in-line, and in-situ process analytical solutions for complex biologics and advanced therapies, enabling rapid measurement of product titer and buffer/excipient concentrations. The NIH awarded Nirrin a $2M grant to further develop its optical spectroscopy technique for rapid characterization of complex biomanufacturing processes.
Summary
NIRRIN TECHNOLOGIES INC is a Biotech company based in Billerica, United States, founded in 2024. It has raised $15.2M in total across 2 rounds, most recently a $6.7M Venture Round round in Jun 2026. Investors include Anzu Partners and BioTools Innovator.
Tech & App Stack
2 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jun 2026
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.

Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...